Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
The New York Times Company is a publishing business based in the US. The New York Times Company shares (NYT) are listed on the NYSE and all prices are listed in US Dollars. The New York Times Company employs 4,700 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$30.46 - $58.65|
|50-day moving average||$49.36|
|200-day moving average||$47.47|
|Wall St. target price||$53.57|
|Dividend yield||$0.24 (0.5%)|
|Earnings per share (TTM)||$0.60|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing The New York Times Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The New York Times Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The New York Times Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 81x. In other words, The New York Times Company shares trade at around 81x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
The New York Times Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.11. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The New York Times Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The New York Times Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $221.9 million.
The EBITDA is a measure of a The New York Times Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.8 billion|
|Operating margin TTM||9.94%|
|Gross profit TTM||$794.4 million|
|Return on assets TTM||4.96%|
|Return on equity TTM||8.06%|
|Market capitalisation||$8 billion|
TTM: trailing 12 months
There are currently 14.1 million The New York Times Company shares held short by investors – that's known as The New York Times Company's "short interest". This figure is 5.2% up from 13.4 million last month.
There are a few different ways that this level of interest in shorting The New York Times Company shares can be evaluated.
The New York Times Company's "short interest ratio" (SIR) is the quantity of The New York Times Company shares currently shorted divided by the average quantity of The New York Times Company shares traded daily (recently around 1.8 million). The New York Times Company's SIR currently stands at 8.01. In other words for every 100,000 The New York Times Company shares traded daily on the market, roughly 8010 shares are currently held short.
However The New York Times Company's short interest can also be evaluated against the total number of The New York Times Company shares, or, against the total number of tradable The New York Times Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The New York Times Company's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 The New York Times Company shares in existence, roughly 80 shares are currently held short) or 0.0859% of the tradable shares (for every 100,000 tradable The New York Times Company shares, roughly 86 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against The New York Times Company.
Find out more about how you can short The New York Times Company stock.
Dividend payout ratio: 25.77% of net profits
Recently The New York Times Company has paid out, on average, around 25.77% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.58% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The New York Times Company shareholders could enjoy a 0.58% return on their shares, in the form of dividend payments. In The New York Times Company's case, that would currently equate to about $0.24 per share.
While The New York Times Company's payout ratio might seem fairly standard, it's worth remembering that The New York Times Company may be investing much of the rest of its net profits in future growth.
The New York Times Company's most recent dividend payout was on 21 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 5 April 2021 (the "ex-dividend date").
The New York Times Company's shares were split on a 2:1 basis on 1 July 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your The New York Times Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for The New York Times Company shares which in turn could have impacted The New York Times Company's share price.
Over the last 12 months, The New York Times Company's shares have ranged in value from as little as $30.4574 up to $58.648. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The New York Times Company's is 0.8483. This would suggest that The New York Times Company's shares are less volatile than average (for this exchange).
The New York Times Company, together with its subsidiaries, provides news and information for readers and viewers across various platforms worldwide. It offers The New York Times (The Times), a daily and Sunday newspaper in the United States, as well as international edition of The Times; and operates the NYTimes. com Website. The company also transmits articles, graphics, and photographs from The Times and other publications to approximately 1,500 newspapers, magazines, and Websites; licenses electronic databases to resellers in the business, professional, and library markets; and offers magazine licensing, news digests, book development, and rights and permissions. In addition, it engages in the live events business, which hosts physical and virtual live events to connect audiences with journalists and outside thought leaders; operates Wirecutter, a product review and recommendation Website that serves as a guide to technology gear, home products, and other consumer goods; develops mobile applications, including games and Cooking products; prints and distributes products for third parties; and offers other products and services. The company was founded in 1851 and is headquartered in New York, New York. .
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.